CATX Lori A Woods buys $50K worth of shares
Apr 02, 2025, 4:33 AM
0.00%
What does CATX do
Perspective Therapeutics, based in Seattle, is a biotechnology company focused on developing radiopharmaceuticals for cancer treatment using the alpha-emitting isotope 212Pb. Their programs for melanoma and neuroendocrine tumors are in Phase I/IIa trials.
Lori A Woods bought 23,475 shares of CATX on 31 March at $2.13 per share, worth a total of $50K. They now own 183,460 CATX shares, or a 15% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.